Shares of Genesco Inc. (NYSE:GCO – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the five analysts that are covering the company, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating and two have assigned a strong buy rating to the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $36.00.
Several equities analysts have issued reports on the company. Wall Street Zen raised Genesco from a “hold” rating to a “buy” rating in a research note on Monday, October 19th. Truist Financial reduced their price objective on shares of Genesco from $40.00 to $38.00 and set a “hold” rating for the company in a research report on Friday, September 4th. Zacks Research upgraded shares of Genesco from a “hold” rating to a “strong-buy” rating in a research note on Friday, September 4th. Finally, Weiss Ratings upgraded shares of Genesco from a “sell (d+)” rating to a “hold (c)” rating in a research note on Tuesday, September 22nd.
Get Our Latest Stock Report on GCO
Institutional Investors Weigh In On Genesco
Large investors have recently bought and sold shares of the stock. Silver Oak Securities Incorporated raised its holdings in shares of Genesco by 3.5% during the first quarter. Silver Oak Securities Incorporated now owns 18,688 shares of the company’s stock valued at $542,000 after purchasing an additional 627 shares during the period. Integrated Wealth Concepts LLC bought a new position in shares of Genesco during the 2nd quarter worth about $25,000. Signaturefd LLC grew its stake in shares of Genesco by 124.2% in the 3rd quarter. Signaturefd LLC now owns 1,455 shares of the company’s stock valued at $50,000 after buying an additional 806 shares during the period. New York State Teachers Retirement System acquired a new stake in shares of Genesco in the 1st quarter valued at about $27,000. Finally, Optiver Holding B.V. grew its stake in shares of Genesco by 550.6% in the 1st quarter. Optiver Holding B.V. now owns 1,106 shares of the company’s stock valued at $32,000 after buying an additional 936 shares during the period. 94.51% of the stock is currently owned by institutional investors and hedge funds.
Genesco Stock Performance
Shares of GCO opened at $37.57 on Monday. The company has a current ratio of 1.58, a quick ratio of 0.32 and a debt-to-equity ratio of 0.03. The stock has a market capitalization of $406.51 million, a P/E ratio of 9.78 and a beta of 1.82. The firm’s fifty day simple moving average is $35.20 and its two-hundred day simple moving average is $33.61. Genesco has a 12 month low of $21.92 and a 12 month high of $43.60.
Genesco (NYSE:GCO – Get Free Report) last issued its quarterly earnings results on Thursday, September 3rd. The company reported ($0.83) earnings per share for the quarter, topping analysts’ consensus estimates of ($1.37) by $0.54. Genesco had a return on equity of 3.14% and a net margin of 1.71%. The firm had revenue of $529.86 million during the quarter, compared to the consensus estimate of $527.26 million. During the same period last year, the business posted ($1.79) EPS. Genesco has set its FY 2027 guidance at 2.000-2.400 EPS. As a group, analysts predict that Genesco will post 2.35 EPS for the current year.
About Genesco
Genesco Inc (NYSE:GCO) is a Nashville, Tennessee-based specialty retailer and distributor of footwear, apparel and accessories. The company serves consumers through retail stores and e-commerce platforms, with a focus on branded footwear and lifestyle products.
Genesco operates several retail banners, including Journeys, which sells trend-focused footwear, apparel and accessories for young consumers; Schuh, a footwear retailer serving the United Kingdom, Ireland and other markets; Johnston & Murphy, a heritage brand offering footwear, apparel, leather goods and accessories; and Little Burgundy, a Canadian footwear retailer.
See Also
- Five stocks we like better than Genesco
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
- Oracle’s AI Spending Peak Is in Sight—Can the Stock Recover?
Receive News & Ratings for Genesco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesco and related companies with MarketBeat.com's FREE daily email newsletter.
